Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High Prevalence of Factor V Leiden in Healthy Jordanian Arabs

1 Jan 1999

Abstract excerpt

The prevalence of APC resistance in healthy Jordanian Arabs was studied. Between October 1996 through September 1997 a total of 400 healthy subjects were studied. There were 212 males and 188 females. APC resistance was studied by functional and DNA methods. There were a total of 52 subjects (13%) who were APC resistant by the functional test. There were 49 subjects (12.25%) who had FV Q506 by DNA test. Of these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation and Thrombosis Mechanisms
Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema
Share to Hemophilia Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10235443
DOI: 10.1055/s-0037-1614528

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High Prevalence of Factor V Leiden in Healthy Jordanian ArabsPMID 10235443Read ↗

Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.Semantic proximity Read ↗

Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.Semantic proximity Read ↗

The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese.Semantic proximity Read ↗

Prevalence of activated protein C resistance (Factor V Leiden) in Lagos, Nigeria.Semantic proximity Read ↗

The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.Semantic proximity Read ↗

Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.Semantic proximity Read ↗

Resistance to activated protein C and factor V Leiden.Semantic proximity Read ↗

Polymorphisms in Factor II and Factor V thrombophilia genes among Circassians in Jordan.Semantic proximity Read ↗

Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain.Semantic proximity Read ↗

Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene.Semantic proximity Read ↗

Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers.Semantic proximity Read ↗

Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.